HPLC法测定人血浆中伏立康唑及其代谢物的浓度

王志君; 杨云云; 张文静; 王学彬; 宋洪杰; 王卓

doi:10.3969/j.issn.1006-0111.2019.02.012

HPLC法测定人血浆中伏立康唑及其代谢物的浓度

doi: 10.3969/j.issn.1006-0111.2019.02.012

海军军医大学附属长海医院药学部, 上海 200433

Determination of voriconazole and its metabolites in human plasma by HPLC

Department of Pharmacy, Changhai Hospital Affiliated to Naval Medical University, Shanghai 200433

摘要: 目的建立一种快速、灵敏、准确、稳定的测定人血浆中伏立康唑及其代谢物浓度的方法，用于伏立康唑临床治疗药物监测。方法采用高效液相色谱（HPLC）-紫外（UV）检测法，以罂粟碱为内标，乙腈蛋白沉淀法处理血浆样品。色谱柱为ACE5C₁₈-AR （150 mm×4.6 mm），流动相为0.025 mol/L磷酸二氢钠（含三乙胺400 μl/L，用0.25 mol/L的氢氧化钠调至pH=7.0）-乙腈（67：33），流速为l ml/min，柱温为40℃，检测波长为255、276 nm （双波长检测），进样量为20 μl。结果伏立康唑氮氧化物、伏立康唑和罂粟碱的保留时间分别为4.5、11.3、13.7 min；血浆中伏立康唑、伏立康唑氮氧化物线性范围均为0.5~20.0 μg/ml （r=0.999 5），定量下限均为0.5 μg/ml，批内、批间RSD均<11%，定量下限、低、中、高梯度浓度提取回收率在90.3%~109.9%之间。结论该方法操作简便，结果准确，适用于伏立康唑的临床治疗药物监测和对其主要代谢物的测定。
- 伏立康唑 /
- 伏立康唑氮氧化物 /
- 高效液相色谱 /
- 治疗药物监测
Abstract: Objective To establish a HPLC method for the determination of the voriconazole concentration in human plasma,which can be used for voriconazole monitoring clinically. Methods High performance liquid chromatography (HPLC-UV) detection method was used with papaverine as internal standard.Acetonitrile protein precipitation method was employed to treat plasma samples.The chromatographic column was ACE5C₁₈-AR150 mm×4.6 mm with the mobile phase 0.025 mol/L sodium dihydrogen phosphate (containing triethylamine 400 μl/L,pH=7.0 adjusted by 0.25 mol/L sodium hydroxide) - acetonitrile (67∶33).The flow rate was l ml/min,the column temperature at 40 ℃,the detection wavelength at 255,276 nm (double wavelength detection) and sampling amount 20 μl. Results The retention time of voriconazole nitrogen oxide,voriconazole and papaverine were 4.5,11.3 and 13.7 min respectively.The linear ranges of voriconazole and voriconazole nitrogen oxides in plasma were 0.5-20.0 μg/ml (r=0.999 5).The quantitative lower limits were 0.5 μg/ml with RSD< 11%.The recovery rates of extraction were between 90.3% and 109.9%. Conclusion This simple and accurate method is suitable for clinical monitoring of voriconazole.
- voriconazole /
- voriconazole nitrogen oxide /
- HPLC /
- therapeutic drug monitoring

[1]	郭天阳,杜安通,杨雅骊,等.第二代三唑类抗真菌药物的研究进展[J].世界临床药物,2014,35(12):715-718.
[2]	CHUWONGWATTANA S,JANTARAROUNGTONG T,CHITASOMBAT M N,et al.A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis[J].Drug Metab Pharmacokinet,2016,31(2):117-122.
[3]	XU G Q,ZHU L Q,GE T Y,et al.Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp.and Aspergillus spp.in children,adolescents and adults by Monte Carlo simulation[J].Int J Antimicrob Agents,2016,47(6):439-445.
[4]	CABRAL-GALEANO E,RUIZ-CAMPS I,LEN-ABAD O,et al.Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital[J].Enferm Infecc Microbiol Clin,2015,33(5):298-302.
[5]	LI Z W,PENG F H, YAN M,et al.Impact of CYP2C19 genotype and liver function on voriconazole pharmacokinetics in renal transplant recipients[J].Ther Drug Monit,2017,39(4):422-428.
[6]	QI F,ZHU L,LI N,et al.Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole[J].Int J Antimicrob Agents,2017,49(4):403-409.
[7]	WANG Y,WANG T,XIE J,et al. Risk factors for voriconazole-associated hepatotoxicity in patients in the intensive care unit[J].Pharmacotherapy,2016,36(7):757-765.
[8]	BRESSÁN I G,MENDEZ M L,GIMENEZ M I.Validation of a reversed-phase ultra-high-performance liquid chromatographic method with photodiode array detection for the determination of voriconazole in human serum and its application to therapeutic drug monitoring[J].Ther Drug Monit,2018,40(2):276-283.
[9]	LIN S C,LIN S W,CHEN J M,et al.Using sweeping-micellar electrokinetic chromatography to sweeping-micellar electrokinetic[J].Talanta,2010,82(2):653-659.
[10]	PEREA S,PENNICK G J, MODAK A,et al.Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma[J].Antimicrob Agents Chemother,2000,44(5):1209-1213.
[11]	刘学松,何为群,陈文英,等.肺部真菌感染患者伏立康唑血药浓度监测的临床应用[J].国际呼吸杂志,2016,36(20):1521-1526.
[12]	GROLL A H,TOWNSEND R,DESAI A,et al.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P4503A4[J].Transpl Infect Dis,2017,19(5):e12751.

[1]	李锐, 张倩倩, 王瑞冬, 高小峰. 国家集中带量采购政策下样本医院良性前列腺增生治疗药物使用情况分析 . 药学实践与服务, 2025, 43(2): 1-6. doi: 10.12206/j.issn.2097-2024.202408031
[2]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[3]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[4]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[5]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[6]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[7]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[8]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[9]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[10]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[11]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 457-460, 502. doi: 10.12206/j.issn.2097-2024.202405059
[12]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[13]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
[14]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[15]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品综合评估 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202312009
[16]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[17]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[18]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[19]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[20]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050

点击查看大图

计量

文章访问数: 3449
HTML全文浏览量: 438
PDF下载量: 376
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

HPLC法测定人血浆中伏立康唑及其代谢物的浓度

doi: 10.3969/j.issn.1006-0111.2019.02.012

Determination of voriconazole and its metabolites in human plasma by HPLC

计量

HPLC法测定人血浆中伏立康唑及其代谢物的浓度

doi: 10.3969/j.issn.1006-0111.2019.02.012

海军军医大学附属长海医院药学部, 上海 200433

English Abstract

Determination of voriconazole and its metabolites in human plasma by HPLC

Department of Pharmacy, Changhai Hospital Affiliated to Naval Medical University, Shanghai 200433

全文HTML

目录

留言板

HPLC法测定人血浆中伏立康唑及其代谢物的浓度

doi: 10.3969/j.issn.1006-0111.2019.02.012

Determination of voriconazole and its metabolites in human plasma by HPLC

计量

出版历程

HPLC法测定人血浆中伏立康唑及其代谢物的浓度

doi: 10.3969/j.issn.1006-0111.2019.02.012

海军军医大学附属长海医院药学部, 上海 200433

English Abstract

Determination of voriconazole and its metabolites in human plasma by HPLC

Department of Pharmacy, Changhai Hospital Affiliated to Naval Medical University, Shanghai 200433

全文HTML

目录